{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:13Z","timestamp":1791216493369,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Startup Fund for Scientifc Research, Fujian Medical University","award":["No.2021QH2033"],"award-info":[{"award-number":["No.2021QH2033"]}]},{"name":"the Startup Fund for Scientifc Research, Fujian Medical University","award":["No.2021QH2033"],"award-info":[{"award-number":["No.2021QH2033"]}]},{"name":"the Natural Science Foundation of Fujian Province","award":["No. 2020J02052"],"award-info":[{"award-number":["No. 2020J02052"]}]},{"name":"the Natural Science Foundation of Fujian Province","award":["No. 2020J02052"],"award-info":[{"award-number":["No. 2020J02052"]}]},{"name":"the Natural Science Foundation of Fujian Province","award":["No. 2020J02052"],"award-info":[{"award-number":["No. 2020J02052"]}]},{"name":"Scientific and Technological Major Special Project of Fujian Provincial Health Commission","award":["No.2021ZD01004"],"award-info":[{"award-number":["No.2021ZD01004"]}]},{"name":"Scientific and Technological Major Special Project of Fujian Provincial Health Commission","award":["No.2021ZD01004"],"award-info":[{"award-number":["No.2021ZD01004"]}]},{"name":"Scientific and Technological Major Special Project of Fujian Provincial Health Commission","award":["No.2021ZD01004"],"award-info":[{"award-number":["No.2021ZD01004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s10753-023-01896-1","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T09:03:52Z","timestamp":1696669432000},"page":"99-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Suppression of IRF9 Promotes Osteoclast Differentiation by Decreased Ferroptosis via STAT3 Activation"],"prefix":"10.1007","volume":"47","author":[{"given":"Chao","family":"Lan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiebin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongze","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifeng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunjie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,7]]},"reference":[{"key":"1896_CR1","first-page":"105","volume":"133","author":"MA Clynes","year":"2020","unstructured":"Clynes, M.A., et al. 2020. The epidemiology of osteoporosis. British Medical Bulletin 133: 105\u2013117.","journal-title":"British Medical Bulletin"},{"key":"1896_CR2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.mcna.2020.06.004","volume":"104","author":"CB Johnston","year":"2020","unstructured":"Johnston, C.B., and M. Dagar. 2020. Osteoporosis in older adults. Medical Clinics of North America 104: 873\u2013884.","journal-title":"Medical Clinics of North America"},{"key":"1896_CR3","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1111\/jgs.17043","volume":"69","author":"PP Coll","year":"2021","unstructured":"Coll, P.P., et al. 2021. The prevention of osteoporosis and sarcopenia in older adults. Journal of the American Geriatrics Society 69: 1388\u20131398.","journal-title":"Journal of the American Geriatrics Society"},{"key":"1896_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.1365.035","volume":"1092","author":"DJ Hadjidakis","year":"2006","unstructured":"Hadjidakis, D.J., and I.I. Androulakis. 2006. Bone remodeling. Annals of the New York Academy of Sciences 1092: 385\u2013396.","journal-title":"Annals of the New York Academy of Sciences"},{"key":"1896_CR5","doi-asserted-by":"crossref","unstructured":"Kim, J.M., C, Lin., Z, Stavre., Greenblatt, M. B., and J.H. Shim. 2020. Osteoblast-osteoclast communication and bone homeostasis. Cells 9.","DOI":"10.3390\/cells9092073"},{"key":"1896_CR6","doi-asserted-by":"publisher","DOI":"10.4110\/in.2018.18.e8","volume":"18","author":"DS Amarasekara","year":"2018","unstructured":"Amarasekara, D.S., et al. 2018. Regulation of osteoclast differentiation by cytokine networks. Immune Netw 18: e8.","journal-title":"Immune Netw"},{"key":"1896_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3389\/fmed.2017.00234","volume":"4","author":"H Bi","year":"2017","unstructured":"Bi, H., et al. 2017. Key Triggers of osteoclast-related diseases and available strategies for targeted therapies: A review. Frontiers of Medicine (Lausanne) 4: 234.","journal-title":"Front Med (Lausanne)"},{"key":"1896_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.773235","volume":"12","author":"YJ Chen","year":"2021","unstructured":"Chen, Y.J., et al. 2021. Upregulation of IRF9 contributes to pulmonary artery smooth muscle cell proliferation during pulmonary arterial hypertension. Frontiers in Pharmacology 12: 773235.","journal-title":"Frontiers in Pharmacology"},{"key":"1896_CR9","first-page":"6540","volume":"61","author":"KE Luker","year":"2001","unstructured":"Luker, K.E., C.M. Pica, R.D. Schreiber, and D. Piwnica-Worms. 2001. Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells. Cancer Research 61: 6540\u20136547.","journal-title":"Cancer Research"},{"key":"1896_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1161\/HYPERTENSIONAHA.113.02083","volume":"63","author":"DS Jiang","year":"2014","unstructured":"Jiang, D.S., et al. 2014. Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin. Hypertension 63: 119\u2013127.","journal-title":"Hypertension"},{"key":"1896_CR11","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1128\/MCB.01498-14","volume":"35","author":"I Rauch","year":"2015","unstructured":"Rauch, I., et al. 2015. Noncanonical effects of IRF9 in intestinal inflammation: More than type I and type III interferons. Molecular and Cellular Biology 35: 2332\u20132343.","journal-title":"Molecular and Cellular Biology"},{"key":"1896_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jaut.2017.03.003","volume":"79","author":"S Smith","year":"2017","unstructured":"Smith, S., et al. 2017. MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE. Journal of Autoimmunity 79: 105\u2013111.","journal-title":"Journal of Autoimmunity"},{"key":"1896_CR13","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1073\/pnas.94.14.7227","volume":"94","author":"X Weihua","year":"1997","unstructured":"Weihua, X., D.J. Lindner, and D.V. Kalvakolanu. 1997. The interferon-inducible murine p48 (ISGF3gamma) gene is regulated by protooncogene c-myc. Proceedings of the National Academy of Sciences of the United States of America\u00a094: 7227\u20137232.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1896_CR14","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.0105-2896.2005.00337.x","volume":"208","author":"H Takayanagi","year":"2005","unstructured":"Takayanagi, H., K. Sato, A. Takaoka, and T. Taniguchi. 2005. Interplay between interferon and other cytokine systems in bone metabolism. Immunological Reviews 208: 181\u2013193.","journal-title":"Immunological Reviews"},{"key":"1896_CR15","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/jbmr.350","volume":"26","author":"G Duque","year":"2011","unstructured":"Duque, G., et al. 2011. Interferon-\u03b3 plays a role in bone formation in vivo and rescues osteoporosis in ovariectomized mice. Journal of Bone and Mineral Research 26: 1472\u20131483.","journal-title":"Journal of Bone and Mineral Research"},{"key":"1896_CR16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/416744a","volume":"416","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi, H., et al. 2002. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416: 744\u2013749.","journal-title":"Nature"},{"key":"1896_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41467-020-20807-8","volume":"12","author":"DE Place","year":"2021","unstructured":"Place, D.E., et al. 2021. Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins. Nature Communications 12: 496.","journal-title":"Nature Communications"},{"key":"1896_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li, J., et al. 2020. Ferroptosis: Past, present and future. Cell Death & Disease 11: 88.","journal-title":"Cell Death & Disease"},{"key":"1896_CR19","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/s41419-019-2064-5","volume":"10","author":"E Park","year":"2019","unstructured":"Park, E., and S.W. Chung. 2019. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death & Disease 10: 822.","journal-title":"Cell Death & Disease"},{"key":"1896_CR20","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1021\/acscentsci.0c01592","volume":"7","author":"Y Fang","year":"2021","unstructured":"Fang, Y., et al. 2021. Inhibiting ferroptosis through disrupting the NCOA4-FTH1 interaction: A new mechanism of action. ACS Central Science 7: 980\u2013989.","journal-title":"ACS Central Science"},{"key":"1896_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fphar.2017.00077","volume":"8","author":"V Jeney","year":"2017","unstructured":"Jeney, V. 2017. Clinical impact and cellular mechanisms of iron overload-associated bone loss. Frontiers in Pharmacology 8: 77.","journal-title":"Frontiers in Pharmacology"},{"key":"1896_CR22","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.bbrc.2016.10.068","volume":"480","author":"X Song","year":"2016","unstructured":"Song, X., et al. 2016. FANCD2 protects against bone marrow injury from ferroptosis. Biochemical and Biophysical Research Communications 480: 443\u2013449.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"1896_CR23","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202101610R","volume":"36","author":"Y Lin","year":"2022","unstructured":"Lin, Y., et al. 2022. Activation of osteoblast ferroptosis via the METTL3\/ASK1-p38 signaling pathway in high glucose and high fat (HGHF)-induced diabetic bone loss. The FASEB Journal 36: e22147.","journal-title":"The FASEB Journal"},{"key":"1896_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.freeradbiomed.2021.04.027","volume":"169","author":"S Ni","year":"2021","unstructured":"Ni, S., et al. 2021. Hypoxia inhibits RANKL-induced ferritinophagy and protects osteoclasts from ferroptosis. Free Radical Biology & Medicine 169: 271\u2013282.","journal-title":"Free Radical Biology & Medicine"},{"key":"1896_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ejphar.2015.03.028","volume":"759","author":"T Komori","year":"2015","unstructured":"Komori, T. 2015. Animal models for osteoporosis. European Journal of Pharmacology 759: 287\u2013294.","journal-title":"European Journal of Pharmacology"},{"key":"1896_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2021.111539","volume":"543","author":"S Xm","year":"2022","unstructured":"Xm, S., et al. 2022. TLR4 inhibition ameliorated glucolipotoxicity-induced differentiation suppression in osteoblasts via RIAM regulation of NF-\u03baB nuclear translocation. Molecular and Cellular Endocrinology 543: 111539.","journal-title":"Molecular and Cellular Endocrinology"},{"key":"1896_CR27","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1186\/s12864-018-5066-2","volume":"19","author":"Y Song","year":"2018","unstructured":"Song, Y., et al. 2018. A comparative analysis of library prep approaches for sequencing low input translatome samples. BMC Genomics 19: 696.","journal-title":"BMC Genomics"},{"key":"1896_CR28","doi-asserted-by":"publisher","first-page":"11058","DOI":"10.1096\/fj.202000771R","volume":"34","author":"B Li","year":"2020","unstructured":"Li, B., et al. 2020. Both aerobic glycolysis and mitochondrial respiration are required for osteoclast differentiation. The FASEB Journal 34: 11058\u201311067.","journal-title":"The FASEB Journal"},{"key":"1896_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-022-00189-x","volume":"10","author":"X Meng","year":"2022","unstructured":"Meng, X., et al. 2022. Estrogen-mediated downregulation of HIF-1\u03b1 signaling in B lymphocytes influences postmenopausal bone loss. Bone Research\u00a010: 15.","journal-title":"Bone Res"},{"key":"1896_CR30","doi-asserted-by":"publisher","first-page":"2353115","DOI":"10.1155\/2022\/2353115","volume":"2022","author":"Y Li","year":"2022","unstructured":"Li, Y., et al. 2022. Energy-stress-mediated AMPK activation promotes GPX4-dependent ferroptosis through the JAK2\/STAT3\/P53 axis in renal cancer. Oxidative Medicine and Cellular Longevity 2022: 2353115.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1896_CR31","first-page":"8223737","volume":"2022","author":"M Li","year":"2022","unstructured":"Li, M., et al. 2022. Melatonin inhibits the ferroptosis pathway in rat bone marrow mesenchymal stem cells by activating the PI3K\/AKT\/mTOR signaling axis to attenuate steroid-induced osteoporosis. Oxidative Medicine and Cellular Longevity 2022: 8223737.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1896_CR32","doi-asserted-by":"publisher","first-page":"7689045","DOI":"10.1155\/2021\/7689045","volume":"2021","author":"WT Chang","year":"2021","unstructured":"Chang, W.T., et al. 2021. A marine terpenoid, heteronemin, induces both the apoptosis and ferroptosis of hepatocellular carcinoma cells and involves the ROS and MAPK pathways. Oxidative Medicine and Cellular Longevity 2021: 7689045.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"1896_CR33","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1146\/annurev.immunol.19.1.623","volume":"19","author":"T Taniguchi","year":"2001","unstructured":"Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka. 2001. IRF family of transcription factors as regulators of host defense. Annual Review of Immunology 19: 623\u2013655.","journal-title":"Annual Review of Immunology"},{"key":"1896_CR34","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","volume":"26","author":"T Tamura","year":"2008","unstructured":"Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annual Review of Immunology 26: 535\u2013584.","journal-title":"Annual Review of Immunology"},{"key":"1896_CR35","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1111\/jcmm.12327","volume":"18","author":"S Salem","year":"2014","unstructured":"Salem, S., et al. 2014. A novel role for interferon regulatory factor 1 (IRF1) in regulation of bone metabolism. Journal of Cellular and Molecular Medicine 18: 1588\u20131598.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"1896_CR36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.5483\/BMBRep.2021.54.9.070","volume":"54","author":"I Kim","year":"2021","unstructured":"Kim, I., et al. 2021. IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-\u03baB\/NFATc1 signaling. BMB Reports 54: 482\u2013487.","journal-title":"BMB Reports"},{"key":"1896_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinsp.2022.100019","volume":"77","author":"X Zhang","year":"2022","unstructured":"Zhang, X., et al. 2022. IRF4 suppresses osteogenic differentiation of BM-MSCs by transcriptionally activating miR-636\/DOCK9 axis. Clinics (S\u00e3o Paulo, Brazil) 77: 100019.","journal-title":"Clinics (S\u00e3o Paulo, Brazil)"},{"key":"1896_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0072033","volume":"8","author":"Y Nakashima","year":"2013","unstructured":"Nakashima, Y., and T. Haneji. 2013. Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss. PLoS ONE 8: e72033.","journal-title":"PLoS ONE"},{"key":"1896_CR39","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1038\/nm.2007","volume":"15","author":"B Zhao","year":"2009","unstructured":"Zhao, B., et al. 2009. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nature Medicine 15: 1066\u20131071.","journal-title":"Nature Medicine"},{"key":"1896_CR40","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.bbadis.2016.06.003","volume":"1862","author":"E Balogh","year":"2016","unstructured":"Balogh, E., et al. 2016. Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin. Biochimica et Biophysica Acta 1862: 1640\u20131649.","journal-title":"Biochimica et Biophysica Acta"},{"key":"1896_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2018.09.033","volume":"133","author":"S Masaldan","year":"2019","unstructured":"Masaldan, S., A.I. Bush, D. Devos, A.S. Rolland, and C. Moreau. 2019. Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration. Free Radical Biology & Medicine 133: 221\u2013233.","journal-title":"Free Radical Biology & Medicine"},{"key":"1896_CR42","doi-asserted-by":"publisher","first-page":"17693","DOI":"10.1074\/jbc.M111.300012","volume":"287","author":"C Latchoumycandane","year":"2012","unstructured":"Latchoumycandane, C., G.K. Marathe, R. Zhang, and T.M. McIntyre. 2012. Oxidatively truncated phospholipids are required agents of tumor necrosis factor \u03b1 (TNF\u03b1)-induced apoptosis. Journal of Biological Chemistry 287: 17693\u201317705.","journal-title":"Journal of Biological Chemistry"},{"key":"1896_CR43","doi-asserted-by":"publisher","first-page":"15395","DOI":"10.1074\/jbc.RA119.010139","volume":"294","author":"Y Yang","year":"2019","unstructured":"Yang, Y., et al. 2019. STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription. Journal of Biological Chemistry 294: 15395\u201315407.","journal-title":"Journal of Biological Chemistry"},{"key":"1896_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102317","volume":"52","author":"S Ouyang","year":"2022","unstructured":"Ouyang, S., et al. 2022. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biology 52: 102317.","journal-title":"Redox Biology"},{"key":"1896_CR45","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/s41419-022-05082-3","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang, W., et al. 2022. Thiostrepton induces ferroptosis in pancreatic cancer cells through STAT3\/GPX4 signalling. Cell Death & Disease 13: 630.","journal-title":"Cell Death & Disease"}],"updated-by":[{"DOI":"10.1007\/s10753-024-02001-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000}}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-023-01896-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01896-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T10:11:32Z","timestamp":1710756692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-023-01896-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,7]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1896"],"URL":"https:\/\/doi.org\/10.1007\/s10753-023-01896-1","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,7]]},"assertion":[{"value":"4 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10753-024-02001-w","URL":"https:\/\/doi.org\/10.1007\/s10753-024-02001-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}